APA

Kobalava Z. D., Pavlikova E. P., Averkov O. A., Merai I., Babaeva L. A., Amirbegishvili I. M., Kotovskaya Y. V. & Moisfev V. S. (20160202). [First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. : Kardiologiia.

Chicago

Kobalava Zh D, Pavlikova E P, Averkov O A, Merai I, Babaeva L A, Amirbegishvili I M, Kotovskaya Yu V and Moisfev V S. 20160202. [First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. : Kardiologiia.

Harvard

Kobalava Z. D., Pavlikova E. P., Averkov O. A., Merai I., Babaeva L. A., Amirbegishvili I. M., Kotovskaya Y. V. and Moisfev V. S. (20160202). [First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. : Kardiologiia.

MLA

Kobalava Zh D, Pavlikova E P, Averkov O A, Merai I, Babaeva L A, Amirbegishvili I M, Kotovskaya Yu V and Moisfev V S. [First Experience of Clinical Application of LCZ696--an AT1-angiotensin Receptors and Neprilysin Inhibitor--in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. : Kardiologiia. 20160202.